Chinese PLA General Hospital
Bo Cao has his expertise in mechanism exploration of metabolic reprogramming and gastric cancer development. His findings uncover the mechanistic associations between glucose, lipid metabolism and cancer progression, further enriching the proof for the hypothesis of metabolism-driven cancer initiation and progress. They also provide novel diagnostic biomarkers, prognostic factors and therapeutic targets for clinical practice of gastric cancer. The regulatory relationships between noncoding RNAs and critical enzymes by the existing studies of Bo Cao.